College | Page 101 of 128 | SpiritIndia.com

Grid computing ‘Mappa mundi’ unveiled in Florida

Visitors to Supercomputing ’06 in Tampa, Florida this week will be the first to see a new interactive map that shows nine of the world’s largest computing Grids. The map, developed by researchers from GridPP in the UK and the European particle physics laboratory, CERN, in Geneva, uses Google Earth to pinpoint Grid sites on six continents, showing more than 300 sites overall. Like the medieval ‘mappa mundi’, which showed what was known of the world at the time, this is one of the first attempts to show the whole scientific Grid world.

Imaging :: New imaging techniques pinpoint heart structure and function

An important first step in using new approaches to treating patients with heart failure – a condition that affects nearly 5 million Americans – requires scientific understanding of the relationship between the form of the heart and function, according to Bijoy K. Khandheria, M.D., FASE, FESC, FACC, chair of the Division of Cardiology at Mayo Clinic in Arizona.

Semen Allergy :: Sex cures women’s semen allergy

Some women experience vaginal itching, burning and other symptoms after sex. They might be allergic to their partner’s semen. According to new research, the extremely rare allergies to seminal fluid can cause symptoms ranging from simple irritation to anaphylactic shock.

Health Care :: NewYork-Presbyterian Ranks Number 1 in New York Magazine’s Best Hospitals Survey

NewYork-Presbyterian Hospital is ranked the overall #1 hospital in New York City, according to New York magazine’s 2006 “Best Hospitals” issue.

Thyroid :: DNA Analysis Could Boost Accuracy of Thyroid Tests

By fine-tuning “fine-needle aspiration” biopsies with a super-fast genetic microarray technology, a team of surgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City says they can greatly enhance the accuracy of these tests.

Hormones :: AMA Adopts Resolution Calling for FDA Oversight of Bioidentical Hormones

The American Medical Association?s (AMA) House of Delegates unanimously and enthusiastically passed a resolution introduced by The Endocrine Society and other concerned organizations urging the U.S. Food and Drug Administration (FDA) to increase its oversight and regulation of so-called bioidentical hormones.

Asthma :: New Studies Reveal What Caregivers See As Key Issues To Facilitate Better Asthma Treatment

In two studies presented during the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI), held in Philadelphia November 9-15, caregivers considered the ?seal of approval? from the FDA to be the most important factor when looking for an effective asthma treatment for their child. Caregivers and physicians also expressed in the study the need for a standardized assessment tool that could help diagnose and monitor asthma.

Wireless Energy Transfer Can Potentially Charge Cell Phones Without Cords

Recharging your laptop computer — and also your cell phone and a variety of other gadgets — might one day be doable in the same convenient way many people now surf the Web: wirelessly. Marin Soljac?ic? of the Massachusetts Institute of Technology will present research by himself and his colleagues Aristeidis Karalis and John Joannopoulos on the physics of electromagnetic fields, showing how wireless energy could power future gadgets. The MIT team is also working on demonstrating the technology in practice. The work will be described on Tuesday, November 14 in San Francisco, at the 2006 American Institute of Physics Industrial Physics Forum (IPF), which will be co-located with the Nanotechnology Topical Conference at the AVS 53rd International Symposium & Exhibition at the Moscone Center West.

Asthma :: Approved Asthma Therapy SYMBICORT Improves Lung Function Safely and Effectively

Newly presented data indicate that treatment with SYMBICORT? (budesonide/formoterol fumarate dihydrate) inhalation aerosol results in significantly greater improvements in lung function, and a lower risk of asthma worsening episodes, compared to budesonide and/or formoterol used alone. In addition, data also showed that SYMBICORT was generally well-tolerated, with an adverse event profile similar to that of its individual components. These study results, involving patients with mild to moderate persistent asthma, were presented today at the American College of Allergy, Asthma & Immunology’s (ACAAI) annual scientific sessions held in Philadelphia on November 9-15, 2006.

Asthma :: PULMICORT RESPULES, budesonide inhalation suspension controls Asthma

Children treated with PULMICORT RESPULES? (budesonide inhalation suspension) either once or twice daily experienced a significantly greater increase in the percentage of asthma-control days compared to those receiving placebo. These results are being presented at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI), held in Philadelphia on November 9-15. Asthma-control days were defined as days when children were free of symptoms and did not use rescue medications during the day and night. Control of asthma symptoms during the day and night and reduction of the need for rescue medication is an important goal of asthma therapy in keeping with current National Asthma Education and Prevention Program (NAEPP) guidelines.